Make a change for good
Improve your company's Environmental, Social and Corporate Governance (ESG) performance
•
Reduce costs
•
Discover new peptide targets
•
Realise a peptide application that wasn't viable previously
•
Improve your company's Environmental, Social and Corporate Governance (ESG) performance • Reduce costs • Discover new peptide targets • Realise a peptide application that wasn't viable previously •
Origin Peptides awarded £7.7 Million Grant
Origin Peptides has been awarded Innovate UK’s Sustainable Medicines Manufacturing Grand Challenge
Peptide-based medicines are one of the fastest-growing areas in pharma, used to treat a wide range of conditions, including Type 2 diabetes and metabolic disease, obesity and weight management, cancer and cardiovascular disease. The global market for these pharmaceuticals is expected to surpass $260B by 2030 (per Grand View Research, Inc).
Origin Peptides Founder and Chief Scientist Sara ten Have explained the significance of winning this grant: “This major award enables us to scale our platform for next-generation peptide synthesis, making production faster, environmentally friendly and far less expensive. It also strengthens the UK’s position as a global leader in this fast-growing pharmaceutical category.”
We’re proud to be working alongside an exceptional consortium, bringing together world-class expertise in bioprocessing, analytical science, and systems engineering: CPI, Queen Mary University and New Gradient.
Doing it greener, cheaper and faster.
Peptides are the small active parts of proteins. They are used for medicines, cosmetics and materials. The way peptides are typically made is with Solid Phase Peptide Synthesis (SPPS)
SPPS is one of the dirtiest industrial chemistry processes currently performed. Peptides are essential, particularly in the research and pharmacology fields, constituting life saving medications and facilitating research which will save lives in the future.
Peptide synthesis is expensive, particularly at scale, which restricts the potential applications of peptides. Enzymatic, materials, construction, food manufacture and environmental applications can now be considered as financially viable with this technology.
Origin Peptides is primarily invested in developing our technology. To facilitate others to utilise this technology for their peptide production needs is our goal, to enable greener, cheaper and faster synthesis. We are also at the cutting edge of applying our technology to the novel application of peptides to all scenarios - and are interested in your questions or problems we might be able to solve.
Why we’re different to the rest
Peptide Synthesis
We’re here to help you.
“Origin Peptides were approached to conduct proteomic analysis on some of our recombinant yeast strains, having heard of their service from colleagues in the field.
Both the work undertaken, and final personalised report was of high quality which thoroughly, and clearly, explained the data collection, analysis as well as any subsequent suggested work packages. These data were also derived from IP-sensitive yeast strains, which were handled with discretion, speed and professionalism.
In addition to wet lab work, we have also routinely used their consultation services to corroborate 3rd party mass spectrometry analysis and provide unbiased insight into equipment procurement.
Altogether working with Origin Peptides has been a positive experience which has strengthened our lab and we recommend their services..”
—Dr Ronan Egan @ Endocryne
Proteomic Consulting
Whether you are wanting to characterise your peptides, or their function, Proteomics is a useful tool to do this.
Through all stages of your experimental journey using proteomics we can help. If you just need one aspect of the process we can accommodate your requirements.
If you have data already and want it assessed with a knowledgeable eye, come and talk to us.
